Works matching AU Zang, Yuan-Sheng

Results: 27

HER2 Splice Site Mutation c.1899‐1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2‐Positive Gastric Adenocarcinoma.

Published in:

Oncologist, 2021, v. 26, n. 9, p. 717, doi. 10.1002/onco.13799

By:

Jiao, Xiao‐Dong;
Liu, Ke;
Wu, Ying;
Zhou, Xin‐Cheng;
Qin, Bao‐Dong;
Ling, Yan;
Liu, Jun;
He, Xi;
Du, Haiwei;
Xiang, Jianxing;
Zang, Yuan‐Sheng

Publication type:

Article

Metastatic Low‐Grade Sarcoma with CARS‐ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.

Published in:

Oncologist, 2021, v. 26, n. 4, p. e524, doi. 10.1002/onco.13543

By:

Jiao, Xiao‐Dong;
Liu, Ke;
Xu, Mingyan;
Yu, Guanzhen;
Liu, Danni;
Huang, Tanxiao;
Qin, Bao‐Dong;
Liu, Ming;
Wu, Ying;
Ling, Yan;
Liu, Jun;
He, Xi;
Wang, Liangzhe;
Li, Yingmei;
Chen, Shifu;
Zang, Yuan‐Sheng

Publication type:

Article

Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.

Published in:

2018

By:

Jiao, Xiao-Dong;
Ding, Chunming;
Zang, Yuan-Sheng;
Yu, Guanzhen

Publication type:

journal article

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.

Published in:

Cancer Medicine, 2019, v. 8, n. 10, p. 4699, doi. 10.1002/cam4.2381

By:

Zang, Yuan‐sheng;
Dai, Chun;
Xu, Xiaoman;
Cai, Xin;
Wang, Guan;
Wei, Jinwang;
Wu, Angela;
Sun, Wending;
Jiao, Shunchang;
Xu, Qiang

Publication type:

Article

Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.677207

By:

Qin, Wenxing;
Qi, Feng;
Guo, Mengzhou;
Wang, Liangzhe;
Zang, Yuan-Sheng

Publication type:

Article

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.681946

By:

Qin, Wenxing;
Qi, Feng;
Li, Jia;
Li, Ping;
Zang, Yuan-Sheng

Publication type:

Article

Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.

Published in:

Cell Biochemistry & Biophysics, 2015, v. 71, n. 3, p. 1325, doi. 10.1007/s12013-014-0352-3

By:

Xie, She-Ling;
Yang, Meng-Hang;
Chen, Kun;
Huang, Hai;
Zhao, Xue-Wei;
Zang, Yuan-Sheng;
Li, Bing

Publication type:

Article

A meta-analysis comparing responses of Asian versus non-Asian cancer patients to PD-1 and PD-L1 inhibitor-based therapy.

Published in:

OncoImmunology, 2020, v. 9, n. 1, p. 1, doi. 10.1080/2162402X.2020.1781333

By:

Peng, Ling;
Qin, Bao-Dong;
Xiao, Kui;
Xu, Song;
Yang, Jin-Song;
Zang, Yuan-Sheng;
Stebbing, Justin;
Xie, Li-Ping

Publication type:

Article

Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8<sup>+</sup>T cells.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 6, p. 1297, doi. 10.1007/s13402-022-00718-0

By:

Yang, Biaolong;
Deng, Biaolong;
Jiao, Xiao-Dong;
Qin, Bao-Dong;
Lu, Yi;
Zhang, Weiqi;
Guo, Yixian;
Chen, Shiqi;
Li, Dan;
Li, Bin;
Zang, Yuan-Sheng

Publication type:

Article

Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report.

Published in:

2022

By:

Wang, Zhan;
Geng, Yan;
Yuan, Ling-Yan;
Wang, Miao-Miao;
Ye, Chen-Yang;
Sun, Li;
Dai, Wei-Ping;
Zang, Yuan-Sheng

Publication type:

Case Study

The Role of Dynamic ctDNA Monitoring During Combination Therapies of BRAF V600E-Mutated Metastatic Colorectal Cancer: A Case Report.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 11849, doi. 10.2147/OTT.S265725

By:

Wang, Zhan;
Ye, Chen-Yang;
Zhou, Wen-Li;
Wang, Miao-Miao;
Dai, Wei-Ping;
Zheng, Jingjing;
Zang, Yuan-Sheng

Publication type:

Article

Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget's Disease Harboring Triple Uncommon HER2 Mutation: A Case Report.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 6289, doi. 10.2147/OTT.S244814

By:

Guo, Jin-Ju;
Jiao, Xiao-Dong;
Wu, Ying;
Qin, Bao-Dong;
Liu, Ke;
Zang, Yuan-Sheng

Publication type:

Article

MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 5143, doi. 10.2147/OTT.S203165

By:

Liu, Ke;
Jiao, Xiao-Dong;
Hao, Jie-Lu;
Qin, Bao-Dong;
Wu, Ying;
Chen, Wei;
Liu, Jun;
He, Xi;
Zang, Yuan-Sheng

Publication type:

Article

Complete response with fluorouracil and irinotecan with a BRAF<sup>V600E</sup> and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 443, doi. 10.2147/OTT.S180845

By:

Wang, Zhan;
Dai, Wei-Ping;
Zang, Yuan-Sheng

Publication type:

Article

The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 4739, doi. 10.2147/OTT.S167346

By:

Qin, Bao-Dong;
Jiao, Xiao-Dong;
Yuan, Ling-Yan;
Liu, Ke;
Wang, Zhan;
Qin, Wen-Xing;
Zang, Yuan-Sheng

Publication type:

Article

Adenosquamous carcinoma of the bile duct: a population-based study.

Published in:

Cancer Management & Research, 2018, v. 10, p. 439, doi. 10.2147/CMAR.S144850

By:

Qin, Bao-Dong;
Jiao, Xiao-Dong;
Yuan, Ling-Yan;
Liu, Ke;
Zang, Yuan-Sheng

Publication type:

Article

A meta-analysis of efficacy and safety of S-1 monotherapy or combination therapy as first-line treatment in metastatic colorectal cancer.

Published in:

International Journal of Colorectal Disease, 2020, v. 35, n. 8, p. 1567, doi. 10.1007/s00384-020-03606-x

By:

Wang, Zhan;
Wang, Miao-Miao;
Zhou, Wen-Li;
Ye, Chen-Yang;
Dai, Wei-Ping;
Liu, Xin-Ling;
Zhang, Gui-Min;
Cheng, Guo-Liang;
Zang, Yuan-Sheng

Publication type:

Article

Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathways.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 2905

By:

Qi, Feng;
Qin, Wen-Xing;
Zang, Yuan-Sheng

Publication type:

Article

Pan‐cancer efficacy and safety of anlotinib plus PD‐1 inhibitor in refractory solid tumor: A single‐arm, open‐label, phase II trial.

Published in:

International Journal of Cancer, 2023, v. 153, n. 4, p. 815, doi. 10.1002/ijc.34546

By:

Qin, Bao‐Dong;
Jiao, Xiao‐Dong;
Wang, Zhan;
Liu, Ke;
Wu, Ying;
Ling, Yan;
Chen, Shi‐Qi;
Zhong, Xue;
Duan, Xiao‐Peng;
Qin, Wen‐Xing;
Xue, Lei;
Guo, Zhen‐Hong;
Zang, Yuan‐Sheng

Publication type:

Article

The Association Between Tumor Burden and the Efficacy of Immunotherapy Among Patients With Non-small Cell Lung Cancer.

Published in:

Cancer Control: Journal of the Moffitt Cancer Center, 2025, p. 1, doi. 10.1177/10732748251320822

By:

Hui, Jia-Jun;
Yan, Han-Lu;
Ding, Sheng-Jun;
Qin, Bao-Dong;
Jiao, Xiao-Dong;
Zang, Yuan-Sheng

Publication type:

Article

New clinical trial design in precision medicine: discovery, development and direction.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01760-0

By:

Duan, Xiao-Peng;
Qin, Bao-Dong;
Jiao, Xiao-Dong;
Liu, Ke;
Wang, Zhan;
Zang, Yuan-Sheng

Publication type:

Article

New clinical trial design in precision medicine: discovery, development and direction.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01760-0

By:

Duan, Xiao-Peng;
Qin, Bao-Dong;
Jiao, Xiao-Dong;
Liu, Ke;
Wang, Zhan;
Zang, Yuan-Sheng

Publication type:

Article

Gout-associated lung disease.

Published in:

2012

By:

Zang, Yuan-Sheng;
Fang, Zheng;
Li, Bing

Publication type:

Journal Article

Gout-associated lung disease.

Published in:

Rheumatology, 2012, v. 51, n. 4, p. 756, doi. 10.1093/rheumatology/ker354

By:

Zang, Yuan-Sheng;
Fang, Zheng;
Li, Bing

Publication type:

Article

Erlotinib Plus Parenteral Nutrition: An Opportunity to Get Through the Hardest Days of Advanced Non-Small Cell Lung Cancer With Cancer Anorexia–Cachexia Syndrome.

Published in:

2013

By:

Zang, Yuan-Sheng;
Fang, Zheng;
Li, Bing

Publication type:

Journal Article

Erlotinib Plus Parenteral Nutrition: An Opportunity to Get Through the Hardest Days of Advanced Non-Small Cell Lung Cancer With Cancer Anorexia–Cachexia Syndrome.

Published in:

American Journal of Hospice & Palliative Medicine, 2013, v. 30, n. 2, p. 210, doi. 10.1177/1049909113476930

By:

Zang, Yuan-Sheng;
Fang, Zheng;
Li, Bing

Publication type:

Article

Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer.

Published in:

2022

By:

Wang, Zhan;
Wang, Miao-Miao;
Geng, Yan;
Ye, Chen-Yang;
Zang, Yuan-Sheng

Publication type:

journal article